Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
UBS
Merck
Moodys
Accenture
Queensland Health

Generated: August 19, 2019

DrugPatentWatch Database Preview

Litigation Details for ABBOTT LABORATORIES v. LUPIN LIMITED (D.N.J. 2009)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

ABBOTT LABORATORIES v. LUPIN LIMITED (D.N.J. 2009)

Docket   Try a Free Trial Date Filed 2009-03-06
Court District Court, D. New Jersey Date Terminated 2011-03-29
Cause 35:271 Patent Infringement Assigned To Garrett E. Brown Jr.
Jury Demand Defendant Referred To Madeline Cox Arleo
Parties ABBOTT LABORATORIES; LABORATORIES FOURNIER S.A.; LUPIN LIMITED; LUPIN PHARMACEUTICALS, INC.
Patents 6,277,405; 6,375,986; 6,652,881; 7,037,529; 7,041,319; 7,276,249; 7,320,802
Attorneys ARNOLD B. CALMANN; CHAD JOHNSON PETERMAN; GEORGE C. JONES; GERALD KROVATIN; GERI L. ALBIN; GERI LAUREN ALBIN; JEFFREY S. SOOS; THOMAS R. CURTIN
Link to Docket External link to docket
Small Molecule Drugs cited in ABBOTT LABORATORIES v. LUPIN LIMITED
The small molecule drug covered by the patents cited in this case is   Try a Free Trial .

Details for ABBOTT LABORATORIES v. LUPIN LIMITED (D.N.J. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-03-06 1 United States Patent Nos. 6,277,405 ("the '405 patent"), 7,037,529 (“the ‘529 patent“): and ?…# 1 Exhibit The 319 Patent, # 2 Exhibit The 405 Patent, # 3 Exhibit The 529 Patent)(ld, ) (Entered: 03…("the '3`19 patent"). The '405, '529, and '319 patents are collectively referred…of: (a) the '405 patent (attached hereto as Exhibit A); (b) the '529 patent (attached hereto as…c) the ‘3]9 patent (attached hereto as Exhibit C). 17. The '405 and '529 patents are titled & External link to document
2009-05-08 13 United States Patent Nos. 6,277,405 (“the ‘405 patent”), 7,037,529 (“the ‘529 patent”), and 7,041,319…of United States Patent Nos. 6,277,405 (“the ‘405 patent”); 7,037,529 (“the ‘529 patent”); and 7,041,… Office (“PTO”) issued U.S. Patent No. 6,277,405 B1 (“the ‘405 patent”), entitled “Fenofibrate Pharmaceutical…405 patent, the ‘986 patent, the ‘881 patent, the ‘529 patent, the ‘319 patent, the ‘249 patent and …405 patent, the ‘986 patent, the ‘881 patent, the ‘529 patent, the ‘319 patent, the ‘249 patent and External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
UBS
Farmers Insurance
Chinese Patent Office
Daiichi Sankyo
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.